Foresee Pharmaceuticals Co., Ltd. (TPEX: 6576)
Health Care · Pharmaceuticals · TW
NT$80.00
+0.38% today · -2.1% 1Y
Foresee Pharmaceuticals Co., Ltd. (TPEX: 6576) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $395.79M and employs 1,760 people.
Over the last twelve months the share price has lost 2.1%, trading between 71.90 and 93.70.
Tweenvest scores Foresee Pharmaceuticals Co., Ltd. across four factors: quality 27/100, value 83/100. Its strongest factor is value.
6576 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $395.79M
- Revenue (TTM)
- $14.81M
- P/E
- —
- EPS
- 0.14
- Dividend yield
- —
- Beta (5Y)
- 0.58
- 52-week high
- NT$93.70
- 52-week low
- NT$71.90
- Avg volume (3M)
- —
- Shares outstanding
- 157.54M
- Employees
- 1,760
- Next earnings
- —
About Foresee Pharmaceuticals Co., Ltd.
Foresee is a Taiwan and US-based biopharmaceutical company focused on two key areas: its unique Stabilized Injectable Formulation (SIF) long-acting injectable technology with derived drug products for specialty markets, and its transformative preclinical and clinical first-in-class New Chemical Entity (NCE) programs targeting rare and severe disease areas with high unmet needs. Its product portfolio includes late and early-stage programs, with its lead product CAMCEVI® used for the treatment of advanced prostate cancer.
- ISIN
- TW0006576002
- Founded
- 2013
- Listed since
- Apr 12, 2016
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.50 | -0.01% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.20 | +0.02% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.52 | -0.18% |
Figures last refreshed Aug 18, 2026.